These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
483 related items for PubMed ID: 28201996
21. Urinary mi-106a for the diagnosis of IgA nephropathy: Liquid biopsy for kidney disease. Szeto CC, Ng JK, Fung WW, Chan GC, Luk CC, Lai KB, Wang G, Chow KM, Mac-Moune Lai F. Clin Chim Acta; 2022 May 01; 530():81-86. PubMed ID: 35278407 [Abstract] [Full Text] [Related]
22. Renal expression of trefoil factor 3 mRNA in association with tubulointerstitial fibrosis in IgA nephropathy. Tanaka K, Sugiyama H, Yamanari T, Mise K, Morinaga H, Kitagawa M, Onishi A, Ogawa-Akiyama A, Tanabe K, Eguchi J, Ohmoto Y, Shikata K, Wada J. Nephrology (Carlton); 2018 Sep 01; 23(9):855-862. PubMed ID: 29987860 [Abstract] [Full Text] [Related]
23. Urinary neutrophil gelatinase-associated lipocalin (NGAL) is an early biomarker for renal tubulointerstitial injury in IgA nephropathy. Ding H, He Y, Li K, Yang J, Li X, Lu R, Gao W. Clin Immunol; 2007 May 01; 123(2):227-34. PubMed ID: 17360238 [Abstract] [Full Text] [Related]
24. Exosomal miR-4639 and miR-210 in Plasma and Urine as Biomarkers in IgA Nephropathy. Zhao S, Sun Y, Mao Q, Zhou C, Chen Y, Xue D. Nephron; 2022 May 01; 146(6):539-552. PubMed ID: 35381590 [Abstract] [Full Text] [Related]
25. Noninvasive Urinary Monitoring of Progression in IgA Nephropathy. Yang JYC, Sarwal RD, Fervenza FC, Sarwal MM, Lafayette RA. Int J Mol Sci; 2019 Sep 10; 20(18):. PubMed ID: 31510053 [Abstract] [Full Text] [Related]
26. Urinary Erythrocyte-Derived miRNAs: Emerging Role in IgA Nephropathy. Duan ZY, Cai GY, Li JJ, Bu R, Chen XM. Kidney Blood Press Res; 2017 Sep 10; 42(4):738-748. PubMed ID: 29050002 [Abstract] [Full Text] [Related]
27. DCR2, a Cellular Senescent Molecule, Is a Novel Marker for Assessing Tubulointerstitial Fibrosis in Patients with Immunoglobulin A Nephropathy. Chen J, Hu W, Xiao F, Lin L, Chen K, Wang L, Wang X, He Y. Kidney Blood Press Res; 2019 Sep 10; 44(5):1063-1074. PubMed ID: 31487717 [Abstract] [Full Text] [Related]
28. Effect of treatment on urinary kidney injury molecule-1 in IgA nephropathy. Seo MS, Park MY, Choi SJ, Jeon JS, Noh H, Kim JK, Han DC, Hwang SD, Jin SY, Kwon SH. BMC Nephrol; 2013 Jul 09; 14():139. PubMed ID: 23837450 [Abstract] [Full Text] [Related]
29. High urinary excretion of kidney injury molecule-1 is an independent predictor of end-stage renal disease in patients with IgA nephropathy. Peters HP, Waanders F, Meijer E, van den Brand J, Steenbergen EJ, van Goor H, Wetzels JF. Nephrol Dial Transplant; 2011 Nov 09; 26(11):3581-8. PubMed ID: 21467131 [Abstract] [Full Text] [Related]
30. Expressions of mRNA for innate immunity-associated functional molecules in urinary sediment in immunoglobulin A nephropathy. Tsuruga K, Aizawa T, Watanabe S, Tsugawa K, Yoshida H, Imaizumi T, Ito E, Tanaka H. Nephrology (Carlton); 2015 Dec 09; 20(12):916-21. PubMed ID: 26058859 [Abstract] [Full Text] [Related]
31. Blood TGF-β1 and miRNA-21-5p levels predict renal fibrosis and outcome in IgA nephropathy. Bharti N, Agrawal V, Kamthan S, Prasad N, Agarwal V. Int Urol Nephrol; 2023 Jun 09; 55(6):1557-1564. PubMed ID: 36648741 [Abstract] [Full Text] [Related]
32. Urinary Matrix Metalloproteinase 7 and Prediction of IgA Nephropathy Progression. Yang X, Ou J, Zhang H, Xu X, Zhu L, Li Q, Li J, Xie D, Sun J, Zha Y, Li Y, Tian J, Liu Y, Hou FF. Am J Kidney Dis; 2020 Mar 09; 75(3):384-393. PubMed ID: 31606236 [Abstract] [Full Text] [Related]
33. Serum miR-192 Is Related to Tubulointerstitial Lesion and Short-Term Disease Progression in IgA Nephropathy. Fan Q, Lu R, Zhu M, Yan Y, Guo X, Qian Y, Zhang L, Dai H, Ni Z, Gu L. Nephron; 2019 Mar 09; 142(3):195-207. PubMed ID: 30808829 [Abstract] [Full Text] [Related]
34. Clinical significance of urinary exosomal microRNAs in patients with IgA nephropathy. Yoon SY, Kim JS, Jung SW, Kim YG, Hwang HS, Moon JY, Lee SH, Seo JW, Seok J, Tae D, Jeong K. Sci Rep; 2023 Oct 11; 13(1):17201. PubMed ID: 37821628 [Abstract] [Full Text] [Related]
35. MicroRNA-155-induced T lymphocyte subgroup drifting in IgA nephropathy. Yang L, Zhang X, Peng W, Wei M, Qin W. Int Urol Nephrol; 2017 Feb 11; 49(2):353-361. PubMed ID: 27796698 [Abstract] [Full Text] [Related]
36. Plasma microRNA signature of patients with IgA nephropathy. Wu J, Zhang H, Wang W, Zhu M, Qi LW, Wang T, Cheng W, Zhu J, Shan X, Huang Z, Zhang L, Chen Y, Sun B, Zhao X, Qian J, Zhu W, Zhou X, Xing C. Gene; 2018 Apr 05; 649():80-86. PubMed ID: 29459010 [Abstract] [Full Text] [Related]
37. Dysregulation of urinary miR-21 and miR-200b associated with interstitial fibrosis and tubular atrophy (IFTA) in renal transplant recipients. Zununi Vahed S, Omidi Y, Ardalan M, Samadi N. Clin Biochem; 2017 Jan 05; 50(1-2):32-39. PubMed ID: 27521993 [Abstract] [Full Text] [Related]
38. Urinary kidney injury molecule-1 is related to pathologic involvement in IgA nephropathy with normotension, normal renal function and mild proteinuria. Xu PC, Wei L, Shang WY, Tian SL, Gu DM, Yan TK, Lin S. BMC Nephrol; 2014 Jul 07; 15():107. PubMed ID: 24998891 [Abstract] [Full Text] [Related]
39. Decreased Expression of Urinary Mammalian Target of Rapamycin mRNA Is Related to Chronic Renal Fibrosis in IgAN. Cao Y, Wang Y, Liu Y, Zhu X, Zhang G, Wang S, Chen X, Liu D, Fu C. Dis Markers; 2019 Jul 07; 2019():2424751. PubMed ID: 31485275 [Abstract] [Full Text] [Related]
40. Evaluation of urinary biomarkers for the prognosis of drug-associated chronic tubulointerstitial nephritis. Shi Y, Su T, Qu L, Wang C, Li X, Yang L. Am J Med Sci; 2013 Oct 07; 346(4):283-8. PubMed ID: 23147380 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]